Midwest Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.89M Buy
42,649
+2,650
+7% +$115K 1.15% 40
2021
Q4
$1.7M Buy
39,999
+3,025
+8% +$127K 1.06% 45
2021
Q3
$1.6M Buy
36,974
+1,395
+4% +$61.7K 1.1% 40
2021
Q2
$1.52M Buy
35,579
+3,028
+9% +$127K 1.09% 43
2021
Q1
$1.26M Buy
32,551
+2,393
+8% +$90.6K 1.02% 43
2020
Q4
$1.08M Buy
+30,158
New +$1.09M 0.99% 48

Other funds holding BSX

Midwest Wealth Management's BSX Position: Q1 2022 in Review

Midwest Wealth Management increased its Boston Scientific (BSX) stake by 6.6% in Q1 2022, buying an estimated $115K and bringing the position to 42,649 shares worth $1.89M. The position accounts for 1.15% of the portfolio, ranked #40.

Midwest Wealth Management first reported a position in BSX in Q4 2020 and has held it in 6 quarters since. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Midwest Wealth Management held 42,649 shares of Boston Scientific worth $1.89M as of Q1 2022.
  • Midwest Wealth Management bought 2,650 Boston Scientific shares in Q1 2022, an estimated $115K.
  • Boston Scientific made up 1.15% of Midwest Wealth Management's portfolio in Q1 2022, its #40 holding.
  • Midwest Wealth Management first reported a position in Boston Scientific in Q4 2020 and has held it in 6 quarters since.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Midwest Wealth Management's 13F filing for Q1 2022, filed 25 May 2022.